Article List

WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2010> 21> 1

Volume: 21 Issue: 1

1. In reply: A large-scale study on the role of ovarian symptom index is necessary.	Page:66—66
2. A hospital-based case-control study of identifying ovarian cancer using symptom index.	Page:65—65
3. Lipoleiomyoma of broad ligament mimicking ovarian cancer in a postmenopausal patient: case report and literature review.	Page:62—64
4. Metastasis to the ovaries from transitional cell carcinoma of the bladder and renal pelvis: a report of two cases.	Page:59—61
5. Cellular fibroma of the ovary containing Leydig cell hyperplasia: a case report.	Page:56—58
6. The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma.	Page:50—55
7. Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment.	Page:45—49
8. Proliferation of CD4(+)CD25(high+)Foxp3(+) regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma.	Page:38—44
9. Expression pattern of the class I homeobox genes in ovarian carcinoma.	Page:29—37
10. Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers.	Page:24—28
11. Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.	Page:18—23
12. Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix.	Page:12—17
13. Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.	Page:3—11
14. Global cooperation in gynecologic cancer.	Page:1—2